Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938
administrator
aspiration-catheter-recall:-q’apel-medical,-inc.-removes-hippo-072-aspiration-system-and-cheetah-delivery-tool-after-fda-warning-letter-about-internal-processes-and-distal-tip-characteristics Healthcare
  • June 16, 2025

Aspiration Catheter Recall: Q’Apel Medical, Inc. Removes Hippo 072 Aspiration System and Cheetah Delivery Tool After FDA Warning Letter About Internal Processes and Distal Tip Characteristics

The Hippo 072 Aspiration System is used to remove stroke-causing clots but there may be issues with the distal tip…
impact-of-patient-access-to-care-on-rates-of-febrile-neutropenia-post-inpatient-administration-of-a-colony-stimulating-factor Health
  • June 16, 2025

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20,…
high-response-rates-with-talquetamab-plus-teclistamab-in-triple-class-refractory-multiple-myeloma Health
  • June 16, 2025

High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma

Talquetamab and teclistamab showed significant promise in a phase 1b/2 dose escalation and expansion trial.
impact-of-a-community-based-specialty-pharmacist-in-identifying-drug-therapy-problems-for-new-adult-oncology-patients Health
  • June 16, 2025

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20,…
camber-announces-launch-of-mycophenolate-mofetil-tablets,-usp Health
  • June 16, 2025

Camber Announces Launch of Mycophenolate Mofetil Tablets, USP

nemolizumab-shows-rapid,-sustained-efficacy-in-atopic-dermatitis Health
  • June 16, 2025

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Nemolizumab shows promising long-term efficacy in reducing itch and skin lesions for atopic dermatitis, enhancing quality of life for patients.
fda-approves-ustekinumab-stba,-biosimilar-to-stelara,-for-pediatric-patients-with-pso-or-psa Health
  • June 16, 2025

FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA

The subcutaneous infusion is indicated for pediatric patients aged 6 to 17 years who weigh less than 60 kg.
keep-looking-up:-a-reflection-on-our-path-forward Health
  • June 16, 2025

Keep Looking Up: A Reflection on Our Path Forward

amazon-restructures-healthcare-business Uncategorized
  • June 16, 2025

Amazon restructures healthcare business

Amazon is reshuffling its various healthcare initiatives into six new divisions, each helmed by a longtime executive or One Medical…
cio-podcast-–-episode-97:-clinical-documentation-improvement-with-faisal-hussain Uncategorized
  • June 16, 2025

CIO Podcast – Episode 97: Clinical Documentation Improvement with Faisal Hussain

For the 97th episode of the CIO podcast hosted by Healthcare IT Today, we are joined by Faisal Hussain, MD,…